Andrew Mcdonald in Homewood, Alabama

Medical School: University Of Alabama School Of Medicine
Graduation Year: 2012
The Primary Medical Specialty for Andrew Mcdonald is listed as: Radiation Oncology
Approximate Years of Experience: 12
PAC (PECOS ID)#: 6103066675
NPI #: 1114286556
NPI Created On: 05/04/2012
NPI Last Updated Listed as: 05/04/2017
Primary Taxonomy Code: 2085R0001X
License Number:
33011
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Management of radiation therapy, complex
2. Calculation of radiation therapy dose
3. Management of modulation radiotherapy planning
4. Radiation treatment devices, design and construction, complex
5. Radiation treatment devices, design and construction, complex
6. Design and construction of device for radiation therapy
7. Radiation treatment management, 5 treatments
8. Radiation treatment management, 5 treatments
9. Stereotactic radiation treatment management of 1 or more lesions using imaging guidance, per treatment course
10. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
11. New patient office or other outpatient visit, typically 45 minutes
12. New patient office or other outpatient visit, typically 45 minutes
13. New patient office or other outpatient visit, typically 60 minutes
14. Established patient office or other outpatient visit, typically 15 minutes
15. Established patient office or other outpatient, visit typically 25 minutes
16. Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
17. Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
18. Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
19. Leuprolide acetate (for depot suspension), 7.5 mg